Growth Metrics

Novartis Ag (NVSEF) Operating Leases (2018 - 2025)

Historic Operating Leases for Novartis Ag (NVSEF) over the last 8 years, with Q4 2025 value amounting to $1.9 billion.

  • Novartis Ag's Operating Leases rose 418510.64% to $1.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 billion, marking a year-over-year increase of 418510.64%. This contributed to the annual value of $1.9 billion for FY2025, which is 418510.64% up from last year.
  • Latest data reveals that Novartis Ag reported Operating Leases of $1.9 billion as of Q4 2025, which was up 418510.64% from -$1.8 billion recorded in Q1 2025.
  • In the past 5 years, Novartis Ag's Operating Leases registered a high of $2.7 billion during Q1 2023, and its lowest value of -$2.0 billion during Q1 2022.
  • Moreover, its 5-year median value for Operating Leases was $146.0 million (2023), whereas its average is $593.1 million.
  • Within the past 5 years, the most significant YoY rise in Novartis Ag's Operating Leases was 418510.64% (2025), while the steepest drop was 17080.5% (2025).
  • Novartis Ag's Operating Leases (Quarter) stood at $1.9 billion in 2021, then plummeted by 98.79% to $23.0 million in 2022, then skyrocketed by 534.78% to $146.0 million in 2023, then crashed by 132.19% to -$47.0 million in 2024, then skyrocketed by 4185.11% to $1.9 billion in 2025.
  • Its Operating Leases was $1.9 billion in Q4 2025, compared to -$1.8 billion in Q1 2025 and -$47.0 million in Q4 2024.